These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37216534)

  • 1. Discovery of phosphorylated lantibiotics with proimmune activity that regulate the oral microbiome.
    Barbour A; Smith L; Oveisi M; Williams M; Huang RC; Marks C; Fine N; Sun C; Younesi F; Zargaran S; Orugunty R; Horvath TD; Haidacher SJ; Haag AM; Sabharwal A; Hinz B; Glogauer M
    Proc Natl Acad Sci U S A; 2023 May; 120(22):e2219392120. PubMed ID: 37216534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lantibiotics: promising candidates for future applications in health care.
    Dischinger J; Basi Chipalu S; Bierbaum G
    Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2.
    Geng M; Austin F; Shin R; Smith L
    Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Lantibiotic Salivaricins: New Weapons to Fight Infectious Diseases.
    Barbour A; Wescombe P; Smith L
    Trends Microbiol; 2020 Jul; 28(7):578-593. PubMed ID: 32544444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I and Class II Lanthipeptides Produced by Bacillus spp.
    Barbosa J; Caetano T; Mendo S
    J Nat Prod; 2015 Nov; 78(11):2850-66. PubMed ID: 26448102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of Gut-Microbiota-Derived Lantibiotics Reveals a Subgroup of S8 Family Proteases for Class III Leader Removal.
    Zhang Y; Hong Z; Zhou L; Zhang Z; Tang T; Guo E; Zheng J; Wang C; Dai L; Si T; Wang H
    Angew Chem Int Ed Engl; 2022 Feb; 61(6):e202114414. PubMed ID: 34889011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the attrition rate of Lanthipeptide discovery for commercial applications.
    Geng M; Smith L
    Expert Opin Drug Discov; 2018 Feb; 13(2):155-167. PubMed ID: 29195488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.
    Birri DJ; Brede DA; Nes IF
    Appl Environ Microbiol; 2012 Jan; 78(2):402-10. PubMed ID: 22101034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for the isolation and characterization of antibacterial lantibiotics.
    Jabes D; Donadio S
    Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
    Escano J; Ravichandran A; Salamat B; Smith L
    Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of lantibiotic biosynthetic machinery promiscuity and its impact on antimicrobial discovery.
    Sandiford SK
    Expert Opin Drug Discov; 2020 Mar; 15(3):373-382. PubMed ID: 31941374
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibacterial immunomodulatory and antibiofilm triple effect of Salivaricin LHM against Pseudomonas aeruginosa urinary tract infection model.
    Mahdi LH; Jabbar HS; Auda IG
    Int J Biol Macromol; 2019 Aug; 134():1132-1144. PubMed ID: 31136751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.
    van Staden ADP; van Zyl WF; Trindade M; Dicks LMT; Smith C
    Appl Environ Microbiol; 2021 Jun; 87(14):e0018621. PubMed ID: 33962984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
    Barbour A; Philip K
    PLoS One; 2014; 9(6):e100541. PubMed ID: 24941127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lantibiotics Produced by Oral Inhabitants as a Trigger for Dysbiosis of Human Intestinal Microbiota.
    Yonezawa H; Motegi M; Oishi A; Hojo F; Higashi S; Nozaki E; Oka K; Takahashi M; Osaki T; Kamiya S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Analysis of Mutacin B-Ny266, a Lantibiotic Active against Caries Pathogens.
    Dufour D; Barbour A; Chan Y; Cheng M; Rahman T; Thorburn M; Stewart C; Finer Y; Gong SG; Lévesque CM
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32229530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic mining of the human microbiome identifies antimicrobial peptides with diverse activity spectra.
    King AM; Zhang Z; Glassey E; Siuti P; Clardy J; Voigt CA
    Nat Microbiol; 2023 Dec; 8(12):2420-2434. PubMed ID: 37973865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the importance of charged residues in lantibiotics.
    Suda S; Hill C; Cotter PD; Ross RP
    Bioeng Bugs; 2010; 1(5):345-51. PubMed ID: 21326835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on characterization, applications and structure-activity relationships of Bacillus species-produced bacteriocins.
    Basi-Chipalu S; Sthapit P; Dhital S
    Drug Discov Ther; 2022 May; 16(2):55-62. PubMed ID: 35466124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.